These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21404147)

  • 41. Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
    Douzenis A; Michopoulos I; Economopoulos T; Lykouras L; Soldatos CR
    Eur J Cancer Care (Engl); 2007 May; 16(3):289-90. PubMed ID: 17508951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alprazolam extended-release in panic disorder.
    Rickels K
    Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental panic provocation in healthy man-a translational role in anti-panic drug development?
    Kellner M
    Dialogues Clin Neurosci; 2011; 13(4):485-93. PubMed ID: 22275853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma interleukin-1 beta concentrations in panic disorder.
    Brambilla F; Bellodi L; Perna G; Bertani A; Panerai A; Sacerdote P
    Psychiatry Res; 1994 Nov; 54(2):135-42. PubMed ID: 7761548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commentary on 'The role of alprazolam for the treatment of panic disorder in Australia'.
    Lampe L
    Aust N Z J Psychiatry; 2012 Mar; 46(3):273-4. PubMed ID: 22391286
    [No Abstract]   [Full Text] [Related]  

  • 46. [Family malediction in the background of panic disorder -- case report].
    Baltás P
    Psychiatr Hung; 2013; 28(4):393-8. PubMed ID: 24443574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconsidering benzodiazepines in the treatment of panic disorder.
    Starcevic V
    Aust N Z J Psychiatry; 2012 Mar; 46(3):271-2. PubMed ID: 22391285
    [No Abstract]   [Full Text] [Related]  

  • 48. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets.
    Sasić S
    Pharm Res; 2007 Jan; 24(1):58-65. PubMed ID: 17048116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral alprazolam acutely increases nucleus accumbens perfusion.
    Wolf DH; Pinkham AE; Satterthwaite TD; Ruparel K; Elliott MA; Valdez J; Smith MA; Detre JA; Gur RC; Gur RE
    Mol Psychiatry; 2013 Sep; 18(9):960-1. PubMed ID: 23070072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The efficiency of alprazolam for seasonal affective disorder (SAD, autumn/winter type)].
    Yamadera H; Nakamura S; Suzuki H; Endo S
    Nihon Ika Daigaku Zasshi; 1997 Feb; 64(1):53-6. PubMed ID: 9119953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
    Soria CA; Remedi C; Núñez DA; D'Alessio L; Roldán EJ
    BMJ Open; 2015 Jul; 5(7):e007231. PubMed ID: 26173716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stiff person syndrome masquerading as panic attacks.
    Ho CS; Ho RC; Wilder-Smith EP
    Lancet; 2014 Feb; 383(9917):668. PubMed ID: 24529469
    [No Abstract]   [Full Text] [Related]  

  • 53. Adverse reaction to generic alprazolam.
    Ross CA
    Am J Psychiatry; 1991 Nov; 148(11):1607. PubMed ID: 1928490
    [No Abstract]   [Full Text] [Related]  

  • 54. Adverse Effects From Counterfeit Alprazolam Tablets.
    Arens AM; van Wijk XM; Vo KT; Lynch KL; Wu AH; Smollin CG
    JAMA Intern Med; 2016 Oct; 176(10):1554-1555. PubMed ID: 27532131
    [No Abstract]   [Full Text] [Related]  

  • 55. CSF corticotropin-releasing factor is not affected in panic disorder.
    Jolkkonen J; Lepola U; Bissette G; Nemeroff C; Riekkinen P
    Biol Psychiatry; 1993 Jan; 33(2):136-8. PubMed ID: 8439604
    [No Abstract]   [Full Text] [Related]  

  • 56. Isolation and structural elucidation of degradation products of alprazolam: photostability studies of alprazolam tablets.
    Nudelman NS; Cabrera CG
    J Pharm Sci; 2002 May; 91(5):1274-86. PubMed ID: 11977103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tablets for sublingual use].
    GIALDI F; PONCI R
    Farmaco Prat; 1953 Jun; 8(6):318-24. PubMed ID: 13095479
    [No Abstract]   [Full Text] [Related]  

  • 58. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alprazolam for depression.
    van Marwijk H; Allick G; Wegman F; Bax A; Riphagen II
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007139. PubMed ID: 22786504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of alprazolam for the treatment of panic disorder in Australia.
    Moylan S; Giorlando F; Nordfjærn T; Berk M
    Aust N Z J Psychiatry; 2012 Mar; 46(3):212-24. PubMed ID: 22391278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.